Cargando…
P011: IPS-7 or IPS-3 to identify very-high risk patients in advanced Classical Hodgkin’s Lymphoma: Which score to choose
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621561/ http://dx.doi.org/10.1097/01.HS9.0000890612.51878.ae |
| _version_ | 1784821585950015488 |
|---|---|
| author | Almeida, Cátia Sousa, Rita Costa E. Roque, Adriana Afonso, Maria Carolina Neves, Dulcelena Guilherme, Raquel Ruzickova, Lenka Carda, José Pedro Geraldes, Catarina Gomes, Marília |
| author_facet | Almeida, Cátia Sousa, Rita Costa E. Roque, Adriana Afonso, Maria Carolina Neves, Dulcelena Guilherme, Raquel Ruzickova, Lenka Carda, José Pedro Geraldes, Catarina Gomes, Marília |
| author_sort | Almeida, Cátia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9621561 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96215612022-11-01 P011: IPS-7 or IPS-3 to identify very-high risk patients in advanced Classical Hodgkin’s Lymphoma: Which score to choose Almeida, Cátia Sousa, Rita Costa E. Roque, Adriana Afonso, Maria Carolina Neves, Dulcelena Guilherme, Raquel Ruzickova, Lenka Carda, José Pedro Geraldes, Catarina Gomes, Marília Hemasphere Advanced Stages Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621561/ http://dx.doi.org/10.1097/01.HS9.0000890612.51878.ae Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Advanced Stages Almeida, Cátia Sousa, Rita Costa E. Roque, Adriana Afonso, Maria Carolina Neves, Dulcelena Guilherme, Raquel Ruzickova, Lenka Carda, José Pedro Geraldes, Catarina Gomes, Marília P011: IPS-7 or IPS-3 to identify very-high risk patients in advanced Classical Hodgkin’s Lymphoma: Which score to choose |
| title | P011: IPS-7 or IPS-3 to identify very-high risk patients in advanced Classical Hodgkin’s Lymphoma: Which score to choose |
| title_full | P011: IPS-7 or IPS-3 to identify very-high risk patients in advanced Classical Hodgkin’s Lymphoma: Which score to choose |
| title_fullStr | P011: IPS-7 or IPS-3 to identify very-high risk patients in advanced Classical Hodgkin’s Lymphoma: Which score to choose |
| title_full_unstemmed | P011: IPS-7 or IPS-3 to identify very-high risk patients in advanced Classical Hodgkin’s Lymphoma: Which score to choose |
| title_short | P011: IPS-7 or IPS-3 to identify very-high risk patients in advanced Classical Hodgkin’s Lymphoma: Which score to choose |
| title_sort | p011: ips-7 or ips-3 to identify very-high risk patients in advanced classical hodgkin’s lymphoma: which score to choose |
| topic | Advanced Stages |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621561/ http://dx.doi.org/10.1097/01.HS9.0000890612.51878.ae |
| work_keys_str_mv | AT almeidacatia p011ips7orips3toidentifyveryhighriskpatientsinadvancedclassicalhodgkinslymphomawhichscoretochoose AT sousaritacostae p011ips7orips3toidentifyveryhighriskpatientsinadvancedclassicalhodgkinslymphomawhichscoretochoose AT roqueadriana p011ips7orips3toidentifyveryhighriskpatientsinadvancedclassicalhodgkinslymphomawhichscoretochoose AT afonsomariacarolina p011ips7orips3toidentifyveryhighriskpatientsinadvancedclassicalhodgkinslymphomawhichscoretochoose AT nevesdulcelena p011ips7orips3toidentifyveryhighriskpatientsinadvancedclassicalhodgkinslymphomawhichscoretochoose AT guilhermeraquel p011ips7orips3toidentifyveryhighriskpatientsinadvancedclassicalhodgkinslymphomawhichscoretochoose AT ruzickovalenka p011ips7orips3toidentifyveryhighriskpatientsinadvancedclassicalhodgkinslymphomawhichscoretochoose AT cardajosepedro p011ips7orips3toidentifyveryhighriskpatientsinadvancedclassicalhodgkinslymphomawhichscoretochoose AT geraldescatarina p011ips7orips3toidentifyveryhighriskpatientsinadvancedclassicalhodgkinslymphomawhichscoretochoose AT gomesmarilia p011ips7orips3toidentifyveryhighriskpatientsinadvancedclassicalhodgkinslymphomawhichscoretochoose |